Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Female Genital Warts”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT05580341
What this trial is testing

Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9

Who this might be right for
Cervical CancerGenital WartCIN+2 more
Shanghai Zerun Biotechnology Co.,Ltd 1,200
Not applicableActive Not RecruitingNCT06197802
What this trial is testing

Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women

Who this might be right for
Cervical CancerCondylomata Acuminata
Xiamen University 392
Large-scale testing (Phase 3)Study completedNCT01245764
What this trial is testing

GARDASIL™ Study in Healthy Females Between 9 and 26 Years of Age in Sub-Saharan Africa (V501-046)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 250
Not applicableStudy completedNCT06700941
What this trial is testing

Impact of HPV Vaccination Against Cervical Lesions and Genital Warts in Colombia. an Ecological Assessment

Who this might be right for
Cervical Intraepithelial Neoplasia (CIN)Genital WartsPapillomavirus Infections+1 more
Universidad Nacional de Colombia 8,000,000
Large-scale testing (Phase 3)UnknownNCT04895020
What this trial is testing

Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years

Who this might be right for
HPV InfectionsCervical CancerVulvar Cancer+12 more
Shanghai Bovax Biotechnology Co., Ltd. 1,200
Not applicableStudy completedNCT06915779
What this trial is testing

Long Term Follow-up of HPV Vaccine in HIV (CTN 236)

Who this might be right for
Cervical CancerHuman Papillomavirus InfectionHuman Immunodeficiency Virus+2 more
University of British Columbia 241
Not applicableStudy completedNCT02520986
What this trial is testing

Carbon Dioxide Laser vs. Electrocoagulation for the Therapy of Condyloma

Who this might be right for
Condylomata Acuminata
Ruhr University of Bochum 140
Large-scale testing (Phase 3)Study completedNCT03532776
What this trial is testing

Comparison Between Podofilox Topical Gel 0.5% and Allergan's Condylox® Gel 0.5% for External Anogenital Warts

Who this might be right for
External Anogenital Warts
Dermax SA 466
Not applicableStudy completedNCT00847340
What this trial is testing

Human Papillomavirus (HPV) Genotypes in Genital Warts in Colombian Population

Who this might be right for
Genital WartsHPV Infections
La Fundacion para la Investigacion y el Desarrollo 342
Post-approval studies (Phase 4)Study completedNCT00862810
What this trial is testing

Alternate Dosing Schedules Study for HPV Vaccine

Who this might be right for
Cervical CancerGenital Warts
Duke University 72
Early research (Phase 1)Study completedNCT03900572
What this trial is testing

Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine

Who this might be right for
HPV Infections
Shanghai Zerun Biotechnology Co.,Ltd 90
Large-scale testing (Phase 3)Study completedNCT04782895
What this trial is testing

Immunogenicity of a Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58)Vaccine(E.Coli) Versus Gardasil®9 in Healthy Females 18-26 Years of Age

Who this might be right for
Cervical CancerCondylomata Acuminata
Xiamen University 488
Not applicableActive Not RecruitingNCT02653118
What this trial is testing

Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021)

Who this might be right for
Cervical CancerVulvar CancerVaginal Cancer+2 more
Merck Sharp & Dohme LLC 4,453
Large-scale testing (Phase 3)Ended earlyNCT05584332
What this trial is testing

A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females

Who this might be right for
Cervical CancerGenital WartCIN1+9 more
Shanghai Bovax Biotechnology Co., Ltd. 3,131
Large-scale testing (Phase 3)Looking for participantsNCT05027776
What this trial is testing

Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years

Who this might be right for
HPV InfectionsCervical Cancer Stage IIaVaginal Cancer+4 more
Shanghai Bovax Biotechnology Co., Ltd. 1,348
Large-scale testing (Phase 3)Study completedNCT00543543
What this trial is testing

Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)

Who this might be right for
Cervical CancerVulvar CancerVaginal Cancer+2 more
Merck Sharp & Dohme LLC 14,840
Testing effectiveness (Phase 2)WithdrawnNCT00365443
What this trial is testing

Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study (V502-003)

Who this might be right for
Cervical CancerCondylomata Acuminata
Merck Sharp & Dohme LLC
Not applicableStudy completedNCT02276521
What this trial is testing

Evaluation of Long Term Immunity Following HPV Vaccination

Who this might be right for
Cervical CancerAnogenital Warts
Murdoch Childrens Research Institute 200
Testing effectiveness (Phase 2)Study completedNCT03935204
What this trial is testing

Immunogenicity Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

Who this might be right for
Condylomata AcuminataCervical Cancer
Xiamen University 627
Testing effectiveness (Phase 2)Study completedNCT00520598
What this trial is testing

Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001)

Who this might be right for
Cervical CancerVulvar CancerVaginal Cancer+2 more
Merck Sharp & Dohme LLC 511
Next Page